Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor

Journal of Endocrinology

Volumn 168, Issue 3, 2001, Pages 409-416

  Dickson, S E ^a   Bicknell, R ^a   Fraser, H M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BROXURIDINE; CD31 ANTIGEN; CELL MARKER; DNA FRAGMENT; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PROGESTERONE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS LUTEUM; ENDOTHELIUM CELL; FEMALE; LUTEAL PHASE; NONHUMAN; OVARY; OVULATION; PERICYTE; PRIMATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SMOOTH MUSCLE; STAINING;

ACTINS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; APOPTOSIS; BROMODEOXYURIDINE; CALLITHRIX; CORPUS LUTEUM; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; FEMALE; IMMUNOENZYME TECHNIQUES; LUTEAL PHASE; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; PROGESTERONE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035078656     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1680409     Document Type: Article

References (22)

1. A plasticity window for blood vessels remodelling is defined by pericyte coverage of the performed endothelial network and is regulated by PDGF-B and VEGF
2. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
3. Blood vessel maturation: Vascular development comes of age
4. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
5. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate
6. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
7. Insulin-like growth factor binding protein-3 (IGFBP-3) mRNA in the endothelial cells of the primate corpus luteum
8. The effects of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
9. Luteal regression in the primate: Different forms of cell death during natural and gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis
10. Suppression of luteal angiogenesis in the primate by neutralization of vascular endothelial growth factor
11. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
12. Endothelial cells modulate the proliferation of mural-cell precursors via platelet-derived growth factor-BB and heterotypic cell contact
13. Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle
14. Angiopoietin-1 induces sprouting angiogenesis in vitro
15. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
16. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy
17. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum
18. Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: A role for estrogens in Sertoli cell development
19. Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey
20. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus)
21. Neovascularization of the corpus luteum of rats during the estrous cycle
22. Cell death during luteal regression in the marmoset monkey (Callithrix jacchus)